Completion Not Excl. Pharmaceutical Discount Club. According To Section 130A (8) Sgb V By An Open House Model To The Active Ingredient Denosumab-Reference: Xgeva (Atc Code According To Who: M05Bx04)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 112920387

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements according to § 130a Paragraph 8 SGB V via medicines with the active ingredient Denosumab (ATC code according to WHO: M05BX04), limited to products wi th the trade name XGEVA, biosimilars that are referenced to the biotechnologically produced original medicine with the trade name XGEVA (R) and corresponding importing products. The contract is concluded as part of a so-called open house model, i.e. h. A conclusion of a contract is open to all interested pharmaceutical companies within the period of participation, provided that they meet and accept the participation requirements. As a result, ind

Mt Ref Id - 112920387

Deadline - Aug 31, 2026